Multiple Phase Cohorts of Nivolumab Monotherapy or Nivolumab Combination Regimens Across Relapsed or Refractory Hematologic Malignancies (CA209-039)

Multiple Phase Cohorts of Nivolumab Monotherapy or Nivolumab Combination Regimens Across Relapsed or Refractory Hematologic Malignancies (CA209-039)

Trial Category:
Hematologic
Contact(s)
Mary Beth Wilwerding, RN
Phone
402-991-8070
Fax
402-991-8850
Location(s)
Nebraska Cancer Specialists, Omaha, NE

This study is looking at the drug Nivolumab alone or in combination with other treatments for various cancers of the blood.  To see if you have one of the cancers that qualify for this study, please contact us.

 
 
Become a NOS Member Today!
 

Platinum Corporate Members

Gold Corporate Members